The Fonds de solidarité FTQ invests US$ 7.5 million in DalCor for Phase 3 trials for patients with Acute Coronary Syndrome

The Fonds's strategy continues to deliver

MONTRÉAL, April 26, 2016 /CNW Telbec/ - The Fonds de solidarité FTQ invests US$ 7.5 million in DalCor Pharmaceutiques for Phase 3 trials of dalcetrapib in genetically distinct patients with Acute Coronary Syndrome or ACS. This is yet another example of the Fonds' contribution to Québec's biotech ecosystem.

DalCor was founded by Sanderling with the support of Québec-based investors.

"Our strategic approach in this sector continues to deliver results", said Alain Denis, Senior Vice-President, Innovation, for the Fonds de solidarité FTQ. "By investing in funds such as Sanderling Ventures VII, we are attracting them to Québec and increasing the availability of capital. Banking on world-class research talent as well as research infrastructures and services, we are helping to strengthen Québec's life sciences industry."

"The work done by a team of researchers at the Montreal Heart Institute, led by Dr Jean-Claude Tardif and Dr Marie-Pierre Dubé, has shown that innovation based on research and precision medicine can represent renewed hope for patients suffering  from diseases such as ACS. The partnership between the MHI, DalCor and Sanderling Ventures, was made possible thanks to the Institute's leading position in the market. This confirms that Québec remains a key player in the worldwide biomedical field", said Mr. Denis.

In recent years, the Fonds has namely invested in DalCor, Inception IBD, enGene, Milestone, Esperas, PRCL Recherche, Gladius, Thrasos, GlyPharma and Zymerworks.

Since 2012, the Fonds also invested in funds such as AmorChem II, CTI II, Forbion, Lumira, Versant V and Sanderling VII.

To read the press release issued by DalCor and the Montreal Heart Institute, please visit DalCor's website.

About the Fonds de solidarité FTQ

The Fonds de solidarité FTQ helps drive our economy. With net assets of $11.2 billion as of November 30, 2015, the Fonds is a development capital fund that channels the savings of Quebecers into investments in all sectors of the economy to help create and maintain jobs and further Québec's development. The Fonds is a partner, either directly or through its network members, in more than 2,550 companies. With more than 600,000 shareholder-savers, the Fonds helps create, maintain and protect more than 176,000 jobs. For more information, visit www.fondsftq.com.

SOURCE Fonds de solidarité FTQ

For media representatives only: Patrick McQuilken, Senior Advisor, Media Relations and Communications, Fonds de solidarité FTQ, Phone: [phone], Mobile : [phone], Email: [email protected]; For Fonds de solidarité FTQ shareholders: Shareholder Services, Fonds de solidarité FTQ, Montréal: 514 383-3663, Québec: 418 628-3663, Toll Free: 1 800 567-3663